WNK2 and adenocarcinoma: However, ADP has been reported to inhibit cell proliferation in LXF-289 cells, an adenocarcinoma-derived cell line from human lung bronchial tumor, by activation of multiple mitogen-activated protein kinase pathways and nuclear factor kappa B1, and by arresting the cells in the S phase via P2Y receptors [28].